Observed and predicted growth responses in prepubertal children with growth disorders: Guidance of growth hormone treatment by empirical variables

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 3, 2010, Pages 1229-1237

  Ranke, Michael B ^a   Lindberg, Anders ^b  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN GROWTH HORMONE;

ADOLESCENT; ARTICLE; BODY HEIGHT; CHILD; CORRELATION ANALYSIS; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; GROWTH DISORDER; GROWTH RATE; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATION; PREDICTION; PREPUBERTY; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SMALL FOR DATE INFANT; TREATMENT RESPONSE; TURNER SYNDROME;

EID: 77749239994     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-1471     Document Type: Article

References (29)

1. Bakker B, Frane J, Anhalt H, Lippe B, Rosenfeld RG 2008 Height velocity targets from the national cooperative growth survey for first-year growth hormone responses in short children. J Clin Endocrinol Metab 93:352-357
2. de Ridder MA, Stijnen T, Hokken-Koelega AC 2007 Prediction of adult height in growth-hormone-treated children with growth hormone deficiency. J Clin Endocrinol Metab 92:925-931
3. Reiter EO, Price DA, Wilton P, Albertsson-Wikland K, Ranke MB 2006 Effect of growth hormone (GH) treatment on the near-final height of 1258 patients with idiopathic GH deficiency: analysis of a large international database. J Clin Endocrinol Metab 91:2047-2054
4. Ranke MB, Guilbaud O, Lindberg A, Cole T 1993 Prediction of the growth response in children with various growth disorders treated with growth hormone: analyses of data from the Kabi Pharmacia International Growth Study. International Board of the Kabi Pharmacia International Growth Study. Acta Paediatr (82 Suppl) 391:82-88
5. Ranke MB, Lindberg A, Albertsson-Wikland K, Wilton P, Price DA, Reiter EO 2005 Increased response, but lower responsiveness, to growth hormone (GH) in very young children (aged 0-3 years) with idiopathic GH deficiency: analysis of data from KIGS. J Clin Endocrinol Metab 90:1966-1971
6. World Medical Association 2008 The Declaration of Helsinki. http://www.wma.net/en/20activities/10ethics/10helsinki/index.html
7. Ranke MB 1991 The Kabi Pharmacia International Growth Study: aetiology classification list with comments. Acta Paediatr Scand Suppl 379:87-92
8. Prader A, Largo RH, Molinari L, Issler C 1989 Physical growth of Swiss children from birth to 20 years of age. First Zurich longitudinal study of growth and development. Helv Paediatr Acta Suppl 52:1-125
9. Karlberg J, Engström I, Karlberg P, Fryer JG 1987 Analysis of linear growth using a mathematical model. I. From birth to three years. Acta Paediatr Scand 76:478-488
10. Lindberg A, Ranke MB 2007 Data analysis within KIGS. In: Ranke M, Price A, Reiter E, eds. Growth hormone therapy in pediatrics - 20 years of KIGS. Basel, Switzerland: Karger; 23-28
11. Ranke MB, Lindberg A, Chatelain P, Wilton P, Cutfield W, Albertsson-Wikland K, Price DA 1999 Derivation and validation of a mathematical model for predicting the response to exogenous recombinant human growth hormone (GH) in prepubertal children with idiopathic GH deficiency. KIGS International Board. Kabi Pharmacia International Growth Study. J Clin Endocrinol Metab 84:1174-1183
12. Ranke MB, Lindberg A, Chatelain P, Wilton P, Cutfield W, Albertsson-Wikland K, Price DA 2000 Prediction of long-term response to recombinant human growth hormone in Turner syndrome: development and validation of mathematical models. KIGS International Board. Kabi International Growth Study. J Clin Endocrinol Metab 85:4212-4218
13. Ranke MB, Lindberg A, Cowell CT, Wikland KA, Reiter EO, Wilton P, Price DA 2003 Prediction of response to growth hormone treatment in short children born small for gestational age: analysis of data from KIGS (Pharmacia International Growth Database). J Clin Endocrinol Metab 88:125-131
14. Raben MS 1958 Treatment of a pituitary dwarf with human growth hormone. J Clin Endocrinol Metab 18:901-903
15. Tanner JM, Whitehouse RH, Hughes PC, Vince FP 1971 Effect of human growth hormone treatment for 1 to 7 years on growth of 100 children, with growth hormone deficiency, low birthweight, inherited smallness, Turner's syndrome, and other complaints. Arch Dis Child 46:745-782
16. Wit JM, Kamp GA, Rikken B 1996 Spontaneous growth and response to growth hormone treatment in children with growth hormone deficiency and idiopathic short stature. Pediatr Res 39:295-302
17. Guyda HJ 1999 Four decades of growth hormone therapy for short children: what have we achieved? J Clin Endocrinol Metab 84:4307-4316
18. Ho KKY 2000 Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. GH Research Society. J Clin Endocrinol Metab 85:3990-3993
19. Van Pareren Y, Mulder P, Houdijk M, Jansen M, Reeser M, Hokken-Koelega A 2003 Adult height after long-term, continuous growth hormone (GH) treatment in short children born small for gestational age: results of a randomized, double-blind, dose-response GH trial. J Clin Endocrinol Metab 88:3584-3590
20. Ranke MB, Lindberg A, Ferrández Longás A, Darendeliler F, Albertsson-Wikland K, Dunger D, Cutfield WS, Tauber M, Wilton P, Wollmann HA, Reiter EO 2007 Major determinants of height development in Turner syndrome (TS) patients treated with GH: analysis of 987 patients from KIGS. Pediatr Res 61:105-110
21. Tanner JM, Whitehouse RH 1976 Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty. Arch Dis Child 51:170-179
22. Tanner JM, Whitehouse RH, Takaishi M 1966 Standards from birth to maturity for height, weight, height velocity, weight velocity: British children, 1965. Arch Dis Child 41:454-471
23. Tanner JM, Whitehouse RH, Takaishi M 1966 Standards from birth to maturity for height, weight, height velocity, weight velocity: British children, 1965. Arch Dis Child 41:613-635
24. Rikken B, Wit JM 1992 Prepubertal height velocity references over a wide age range. Arch Dis Child 67:1277-1280
25. Ranke MB, Price DA, Albertsson-Wikland K, Maes M, Lindberg A 1997 Factors determining pubertal growth and final height in growth hormone treatment of idiopathic growth hormone deficiency. Analysis of 195 patients of the Kabi Pharmacia International Growth Study. Horm Res 48:62-71
26. Kuczmarski R, Ogden C, Grummer-Strawn L, Flegal K, Guo S, Wei R, Mei Z, Curtin L, Roche A, Johnson C 2000 CDC growth charts: United States advance data from vital and health statistics: no. 314. Hyattsville, MD: National Center for Health Statistics
27. Cole T 2004 Growth reference standards. In: Nocoletti I, Benso L, Gilli G, eds. Physiological and pathological auxology. Firenze, Italy: Edizioni Centro Studi Auxologici; 161-174
28. Ranke MB, Lindberg A, Price DA, Darendeliler F, Albertsson-Wikland K, Wilton P, Reiter EO 2007 Age at growth hormone therapy start and first-year responsiveness to growth hormone are major determinants of height outcome in idiopathic short stature. Horm Res 68:53-62
29. Ranke MB, Stubbe P, Majewski F, Bierich JR 1988 Spontaneous growth in Turner's syndrome. Acta Paediatr Scand Suppl 343:22-30